MEDIZEN HUMANCARE

XKON-236340
Korea New Exchange NYSE
Commercial Physical and Biological Research
Global Rank
#44514
Country Rank
n/a
Market Cap
3.4 M
Price
1.48
Change (%)
7.73%
Volume
2,509

MEDIZEN HUMANCARE's latest marketcap:

3.4 M

As of 06/06/2025, MEDIZEN HUMANCARE's market capitalization has reached $3.4 M. According to our data, MEDIZEN HUMANCARE is the 44514th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 3.4 M
Revenue (ttm) 0
Net Income (ttm) 0
Shares Out 2.3 M
EPS (ttm) 0
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date n/a
Market Cap Chart
Data Updated: 06/06/2025

MEDIZEN HUMANCARE's yearly market capitalization.

MEDIZEN HUMANCARE has seen its market value drop from ₩19.18 B to ₩4.66 B since 2020, representing a total decrease of 75.72% and an annual compound decline rate (CAGR) of 27.32%.
Date Market Cap Change (%)
06/06/2025 ₩4.66 B -35.87%
12/30/2024 ₩7.26 B -21.25%
12/28/2023 ₩9.22 B -33.88%
12/29/2022 ₩13.94 B -13.57%
12/30/2021 ₩16.13 B -15.87%
12/30/2020 ₩19.18 B

Company Profile

About MEDIZEN HUMANCARE Inc.

MEDIZEN HUMANCARE Inc. is a leading research company specializing in genomic analysis to predict diseases on an individual basis. Operating across Asia, the Americas, Europe, and internationally, the company leverages cutting-edge technology to provide personalized healthcare insights.

Key Services

  • M-CHECK: Analyzes patients' risk for genetic diseases using genomic variation packages tailored to specific conditions. Utilizes advanced gene chips and analysis kits for precise results.
  • MELTHY (DTC): A direct-to-consumer DNA analysis service designed to offer actionable health and wellness insights.

Company Background

Founded in 2012, MEDIZEN HUMANCARE Inc. is headquartered in Seoul, South Korea. The company is dedicated to advancing genomic research and improving preventive healthcare solutions worldwide.

Frequently Asked Questions

  • What is MEDIZEN HUMANCARE's (XKON-236340) current market cap?
    As of 06/06/2025, MEDIZEN HUMANCARE (including the parent company, if applicable) has an estimated market capitalization of $3.4 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • MEDIZEN HUMANCARE global market capitalization ranking is approximately 44514 as of 06/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.